66640-93-5

66640-93-5 structure
66640-93-5 structure
  • Name: L-Eflornithine
  • Chemical Name: C780YUS9YI
  • CAS Number: 66640-93-5
  • Molecular Formula: C6H12F2N2O2
  • Molecular Weight: 182.169
  • Catalog: Research Areas Cancer
  • Create Date: 2018-07-05 19:51:06
  • Modify Date: 2025-08-25 09:05:04
  • L-Eflornithine (L-DFMO) is an enantiomer of Eflornithine. L-Eflornithine is an irreversible ornithine decarboxylase (ODC) inhibitor with a KD of 1.3±0.3 µM, and a Kinact of 0.15±0.03 min-1[1].

Name C780YUS9YI
Synonyms C780YUS9YI
2-(Difluoromethyl)-L-ornithine
EFLORNITHINE, (S)-
MFCD00242734
L-Ornithine, 2-(difluoromethyl)-
(2S)-2,5-diamino-2-(difluoromethyl)pentanoic acid
(S)-eflornithine
Description L-Eflornithine (L-DFMO) is an enantiomer of Eflornithine. L-Eflornithine is an irreversible ornithine decarboxylase (ODC) inhibitor with a KD of 1.3±0.3 µM, and a Kinact of 0.15±0.03 min-1[1].
Related Catalog
Target

KD:1.3±0.3 µM (Ornithine decarboxylase, ODC)[1]

In Vitro Eflornithine (D/L-DFMO) is an inhibitor of ODC, the first enzyme in eukaryotic polyamine biosynthesis. Both enantiomers of Eflornithine (DFMO) irreversibly inactivate ODC. Both Eflornithine enantiomers (L-Eflornithine and D-Eflornithine) suppress ODC activity in a time- and concentration-dependent manner. The inhibitor dissociation constant (KD) values for the formation of enzyme-inhibitor complexes are 28.3±3.4, 1.3±0.3 and 2.2±0.4 µM respectively for D-Eflornithine, L-Eflornithine and Eflornithine. The inhibitor inactivation constants (Kinact) for the irreversible step were 0.25±0.03, 0.15±0.03 and 0.15±0.03 min-1 respectively for D-Eflornithine, L-Eflornithine and Eflornithine. Treatment of human colon tumour-derived HCT116 cells with either L-Eflornithine or D- Eflornithine decreases the cellular polyamine contents in a concentration-dependent manner[1]. The enantiomers display different potencies in vitro, with the L-enantiomer having up to a 20-fold higher affinity for the target enzyme ornithine decarboxylase[2]. The L-Eflornithine also appears to be more potent in cultured T.brucei gambiense parasites[2].
In Vivo The more potent L-Eflornithine is present at much lower concentrations in both plasma and cerebrospinal fluid (CSF) than those of the D-Eflornithine. The plasma concentrations of L-Eflornithine are on average 52% of the D-enantiomer concentrations. The typical oral clearances of L-Eflornithine and D-eflornithine are 17.4 and 8.23 liters/h, respectively[2].
References

[1]. Qu N, et al. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine. Biochem J. 2003 Oct 15;375(Pt 2):465-70.

[2]. Jansson-Löfmark R, et al. Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness. Antimicrob Agents Chemother. 2015 Feb;59(2):1299-307.

Density 1.3±0.1 g/cm3
Boiling Point 347.0±42.0 °C at 760 mmHg
Molecular Formula C6H12F2N2O2
Molecular Weight 182.169
Flash Point 163.7±27.9 °C
Exact Mass 182.086685
LogP 0.29
Vapour Pressure 0.0±1.6 mmHg at 25°C
Index of Refraction 1.462
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.